Order Article Reprints

Saito M, Mori A, Ishio T, Kobayashi M, Tsukamoto S, Kajikawa S, Yokoyama E, Kanaya M, Izumiyama K, Muraki H, et al. Initial Efficacy of the COVID-19 mRNA Vaccine Booster and Subsequent Breakthrough Omicron Variant Infection in Patients with B-Cell Non-Hodgkin’s Lymphoma: A Single-Center Cohort Study. Viruses. 2024; 16(3):328. https://doi.org/10.3390/v16030328

Saito, Makoto, Akio Mori, Takashi Ishio, Mirei Kobayashi, Shihori Tsukamoto, Sayaka Kajikawa, Emi Yokoyama, Minoru Kanaya, Koh Izumiyama, Haruna Muraki, and et al. 2024. "Initial Efficacy of the COVID-19 mRNA Vaccine Booster and Subsequent Breakthrough Omicron Variant Infection in Patients with B-Cell Non-Hodgkin’s Lymphoma: A Single-Center Cohort Study" Viruses 16, no. 3: 328. https://doi.org/10.3390/v16030328

Saito, M., Mori, A., Ishio, T., Kobayashi, M., Tsukamoto, S., Kajikawa, S., Yokoyama, E., Kanaya, M., Izumiyama, K., Muraki, H., Morioka, M., & Kondo, T. (2024). Initial Efficacy of the COVID-19 mRNA Vaccine Booster and Subsequent Breakthrough Omicron Variant Infection in Patients with B-Cell Non-Hodgkin’s Lymphoma: A Single-Center Cohort Study. Viruses, 16(3), 328. https://doi.org/10.3390/v16030328